Research shows sotagliflozin is the first medication of its kind to significantly reduce both heart attacks and strokes
Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with ...
Science Daily16h
Mpox: Better understanding of tecovirimat resistance
A virus originally found in animals, mpox -- which causes the disease of the same name -- is now circulating in humans. Since 2022, it has been the cause of major epidemics spreading outside endemic ...
Understanding how twice-a-year Inclisiran therapy can transform cholesterol management, and the challenges facing adoption of this new drug
To understand the full scope of this medication -- its effectiveness, risks, and who stands to benefit the most -- ...